Tag Archives: U.S.

EDB Postgres Advanced Server Security Technical Implementation Guide for Windows Now Available to U.S. Government Agencies

EDB STIG is the only guide for fast, secure implementation of PostgreSQL on Windows BEDFORD, Mass., August 27, 2020 – EDB, a leading contributor to PostgreSQL, today announced that the Defense Information Systems Agency (DISA) has approved the Security Technical Implementation Guide (STIG) for EDB Postgres™ Advanced Server (EPAS) on Microsoft Windows. The only STIG… Read More »

U.S. tops 5 million coronavirus cases as outbreak threatens America’s Midwest

Medics transfer a patient on a stretcher from an ambulance outside of Emergency at Coral Gables Hospital where Coronavirus patients are treated in Coral Gables near Miami, on July 30, 2020. Chandan Khanna | AFP | Getty Images The United States has surpassed 5 million Covid-19 cases, a grisly milestone that represents roughly a quarter… Read More »

Dr. Birx warns U.S. in new phase of coronavirus pandemic with ‘extraordinarily widespread’ cases

Deborah Birx, coronavirus response coordinator for the White House Coronavirus Task Force, speaks after a White House Coronavirus Task Force briefing at the Department of Health and Human Services on June 26, 2020 in Washington, DC. Joshua Roberts | Getty Images Dr. Deborah Birx, the White House coronavirus task force coordinator, said on Sunday that the… Read More »

U.S. government gives Moderna Inc $472 million for coronavirus vaccine development

A view of Moderna headquarters on May 08, 2020 in Cambridge, Massachusetts. Moderna was given FDA approval to continue to phase 2 of Coronavirus (COVID-19) vaccine trials with 600 participants. (Photo by Maddie Meyer/Getty Images) Moderna Inc., a biotech company that develops pharmaceuticals, received $ 472 million award from the federal Biomedical Advanced Research and… Read More »

Return-To-School Is Stressing Out U.S. Parents Across Income, Race and Political Party

The worse of the coronavirus pandemic is yet to come, most Americans felt in July 2020. That foreboding feeling is shaping U.S. parents’ concerns about their children returning to school, with the calendar just weeks away from educators opening their classrooms to students, from kindergarten to the oldest cohort entering senior year of high school.… Read More »

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »